Abbott announced its financial results for the fourth quarter and full year of 2021. In the fourth quarter, net sales reached $11.468 billion, representing a 7.2% increase year-over-year; net profit was $1.989 billion compared to $2.162 billion in the same period last year. By business segment, revenue from the medical device division was $3.749 billion, up 15.1% year-over-year. Diagnostic business sales were $4.471 billion, increasing by 2.9%. Pharmaceutical business sales amounted to $1.203 billion, growing 4.9% year-over-year. Nutrition business sales were $2.043 billion, reflecting a 5.5% year-over-year increase. For the full year 2021, net sales totaled $43.075 billion, compared to $34.608 billion in 2020. The annual net profit was $7.071 billion, versus $4.495 billion in the previous year.
Danaher Corporation (Danaher) announced its financial results for the fourth quarter and full year of 2021. Fourth-quarter sales were $8.148 billion, compared to $6.76 billion in the same period last year. Net profit for the quarter was $1.747 billion, compared to $1.2 billion in the same period last year. Full-year 2021 sales reached $29.453 billion, compared to $22.284 billion in 2020. Annual net profit was $6.269 billion, compared to $3.51 billion in the previous year.
Medtronic Announces Financial Results for the Third Quarter of Fiscal Year 2022. Net sales for the quarter were $7.763 billion, compared to $7.775 billion in the same period last year; net profit attributable to the company was $1.48 billion, compared to $1.27 billion in the same period last year, representing a year-over-year increase of 16.5%. By business segment, cardiovascular revenue was $2.745 billion, up 1% year-over-year; medical surgical revenue was $2.29 billion, down 1% year-over-year; neuroscience revenue was $2.144 billion, up 1% year-over-year; diabetes revenue was $584 million, down 7% year-over-year. Revenue from the U.S. region was $3.939 billion, accounting for 50.8% of the company’s total revenue.
Baxter International Inc. announced its financial results for the fourth quarter and full year of 2021. The net sales in the fourth quarter were $3.514 billion, compared to $3.181 billion in the same period last year. The net profit for the quarter was $238 million, compared to $168 million in the same period last year. The net sales for the full year of 2021 were $12.784 billion, compared to $11.673 billion in 2020. The net profit for the full year was $1.284 billion, compared to $1.102 billion in the previous year.
Henry Schein Announces Fourth Quarter and Full Year 2021 Results. Net sales for the fourth quarter were $3.331 billion, compared to $3.166 billion in the same period last year. Quarterly net profit was $147 million, compared to $143 million in the same period last year. Net sales for the full year 2021 were $12.4 billion, compared to $10.12 billion in 2020. Full-year net profit was $631 million, compared to $404 million in the previous year.
Boston Scientific announced its Q4 and full-year 2021 financial results. Net sales for Q4 were $3.127 billion, compared to $2.708 billion in the same period last year. Quarterly net profit was $80 million, down from $196 million in the same quarter last year. For the full year 2021, net sales reached $11.888 billion, compared to $9.913 billion in 2020. The annual net profit was $985 million, reversing a net loss of $115 million in the previous year.
Owens & Minor announced its financial results for the fourth quarter and full year of 2021. The net revenue for the fourth quarter was $2.467 billion, compared to $2.362 billion in the same period last year. The net profit for the quarter was $41.98 million, compared to $50.74 million in the same period last year. The net revenue for 2021 was $9.785 billion, compared to $8.48 billion in 2020. The net profit for the full year was $221 million, compared to $29.87 million in the previous year.
3M Reports Fourth-Quarter and Full-Year 2021 Results. Fourth-quarter net sales were $8.612 billion, with a net profit of $1.339 billion. Full-year 2021 net sales were $35.355 billion, with a net profit of $5.921 billion. Healthcare product sales for the fourth quarter were $2.306 billion, with full-year sales of $8.445 billion.
Alcon announced its financial results for the fourth quarter and full year of 2021. Revenue for the fourth quarter was $2.149 billion, compared to $1.94 billion in the same period last year. Net profit for the quarter was $139 million, up from $95 million in the same period last year. Revenue for the full year 2021 was $8.291 billion, compared to $6.833 billion in 2020. Full-year net profit was $376 million, compared to a net loss of $531 million in the previous year.
Zimmer Biomet Holdings Inc. announced its financial results for the fourth quarter and full year of 2021. The net sales in the fourth quarter were $2.038 billion, compared to $2.085 billion in the same period last year. The company reported a net loss of $84 million for the quarter, while it had a net profit of $334 million in the same period last year. The net sales for the full year of 2021 were $7.836 billion, compared to $7.024 billion in 2020. The net profit for the whole year was $402 million, while the company reported a net loss of $139 million in the previous year.
Olympus (OLYMPUS) announced its financial results for the first nine months of the fiscal year ended December 31, 2021. Revenue for the period was 629.757 billion yen (approximately 4.93 billion US dollars), compared to 513.584 billion yen in the same period last year. Operating profit for the period was 108.91 billion yen, compared to 64.734 billion yen in the same period last year. Net profit for the period was 87.667 billion yen, compared to 1.624 billion yen in the same period last year.
Terumo Announces Financial Results for the First 9 Months of the Fiscal Year Ending December 31, 2021. Revenue for the period was 523.482 billion yen (approximately 4.094 billion USD), compared to 448.628 billion yen in the same period last year. Operating profit for the period was 94.455 billion yen, compared to 75.272 billion yen in the same period last year. Net profit for the period was 71.696 billion yen, compared to 58.601 billion yen in the same period last year.
Canon Group Releases Fiscal 2021 Earnings Report. In 2021, the group's revenue increased by 11.2% year-on-year to 3,513.357 billion yen, with a net profit growth of 157.7%. Among this, the medical business revenue grew by 10.2% to 480.4 billion yen (approximately 3.76 billion U.S. dollars).
Mindray Medical Releases 2021 Annual Report: Company Achieves Revenue of 25.27 Billion Yuan (Approx. 3.956 Billion USD), a Year-on-Year Increase of 20.18%; Net Profit Attributable to Shareholders of Listed Companies is 8.002 Billion Yuan, a Year-on-Year Increase of 20.19%.
Source: PharmaHealth News
Follow our WeChat Official Account
Get More Information
